February 21, 2024
1 min watch
Save
VIDEO: Tapinarof effective in treating psoriasis in skinfold areas
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this Healio exclusive video, Raj Chovatiya, MD, PhD, discussed research into the topical AhR modulator tapinarof from the Maui Derm 2024 meeting.
Chovatiya, assistant professor of dermatology at Northwestern University Feinberg School of Medicine, discussed a study examining the use of tapinarof (Vtama, Dermavant) in treating patients with mild to severe intertriginous plaque psoriasis.
“What the study showed is that, indeed, independent of whether you have psoriasis on the elbows or knees, if you have it in these skinfold areas, you can get very similar efficacy, both in terms of symptomatic improvement and improvement of skin signs,” Chovatiya said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interview
Disclosures:
Chovatiya reports being an advisor, consultant, speaker and/or investigator for AbbVie, Apogee Therapeutics, Arcutis, Argenx, ASLAN Pharmaceuticals, Beiersdorf, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Dermavant, Eli Lilly and Company, FIDE, Galderma, Genentech, GSK, Incyte, Janssen, LEO Pharma, L’Oréal, Nektar Therapeutics, Opsidio, Pfizer Inc., Regeneron, RAPT, Sanofi and UCB.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.